Aarti Drugs Q2 Results
- BSE: 524348
- NSE: AARTIDRUGS
- ISIN: INE767A01016
- Sector: Biotechnology & Drugs
BSE
422.95
3.20 (0.76%)
3.20 (0.76%)Volume17.11 K
Updated: Fri 17 Jul, 2026 | 15:40:09
NSE
422.302.40 (0.57%)
2.40 (0.57%)Volume2.21 L
Updated: Fri 17 Jul, 2026 | 15:42:22
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Aarti Drugs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 584.77 | 531.15 | 10.10% | 545.01 | 7.30% |
| Depreciation/ Amortization | 16.26 | 14.72 | 10.46% | 13.72 | 18.51% |
| Operating Income | 68.02 | 59.36 | 14.59% | 53.32 | 27.57% |
| Net Income | 45.28 | 53.91 | -16.01% | 35.01 | 29.35% |
| Other Operating Expenses Total | 127.15 | 112.24 | 13.28% | 110.73 | 14.83% |
| Net Income Before Taxes | 60.41 | 51.11 | 18.20% | 45.88 | 31.67% |
| Total Revenue | 652.79 | 590.51 | 10.55% | 598.33 | 9.10% |
| Selling/ General/ Admin Expenses Total | 33.07 | 30.80 | 7.37% | 26.56 | 24.51% |
| Diluted Normalized EPS | 4.95 | 5.91 | -16.24% | 3.83 | 29.24% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.